# The Effects of Sedatives on Tobacco Use Disorder Version 2

> **NCT05505630** · EARLY_PHASE1 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 20 (actual)

## Conditions studied

- Tobacco Smoking

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Midazolam
- **DRUG:** Dexmedetomidine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05505630
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-31
- **Primary completion:** 2025-12-10
- **Final completion:** 2025-12-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05505630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05505630, "The Effects of Sedatives on Tobacco Use Disorder Version 2". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05505630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*